title: Treatment Factors That Influence Mortality in Acromegaly.
abstract: Acromegaly is a rare condition characterized by excessive secretion of growth hormone (GH), which is almost always due to a pituitary adenoma. Acromegaly is associated with significant morbidity such as hypertension, type 2 diabetes, cardiomyopathy, obstructive sleep apnoea, malignancy and musculoskeletal abnormalities. Acromegaly has also been associated with increased mortality in several retrospective studies. This review will focus on the epidemiological data relating to mortality rates in acromegaly, the relationship between acromegaly and malignancy, the role of GH and insulin-like growth factor-I in assessing the risk of future mortality, and the impact of radiotherapy and hypopituitarism on mortality.
authors: Department of Endocrinology, Adelaide and Meath Hospital incorporating the National Children's Hospital, Tallaght, Ireland.
authors: John
authors: J
authors: McCabe
authors: John
authors: J
authors: Ayuk
authors: Mark
authors: M
authors: Sherlock
mesh_terms: D000172:Acromegaly; D000236:Adenoma / Q000188:drug therapy* / Q000401:mortality*; D013006:Growth Hormone / Q000378:metabolism; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D007018:Hypopituitarism / Q000150:complications / Q000188:drug therapy; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D019382:Human Growth Hormone; D013006:Growth Hormone